4776e964dc7de038945b3fe9458643fe
HURO PATH Filter (FNA)
CELLTRAZONE CO., LTD.·I·Ecuador ARCSA·Registered November 24, 2022
Device classification
- Risk class
- I
- Product type
- In Vitro Diagnostic
- Brand name
- CelltraZone
- Commercial name
- 15-190 Tissue processors
- Sterilization method
- METHODOLOGY: HISTOCHEMISTRY AND CYTOCHEMISTRY
Registration information
- Analysis ID
- 4776e964dc7de038945b3fe9458643fe
- Registration date
- November 24, 2022
- Expiration date
- November 24, 2027
- Creation date
- November 24, 2022
Manufacturer
- City
- GIMPO-SI
- Country
- KOREA, REPUBLIC OF
- Address
- 1FLOOR, 6FLOOR, 16, ARAYUK-RO, GOCHON-EUP, GIMPO-SI, GYEONGGI-DO, REPUBLICA DE KOREA
Product owner
- Name
- CELLTRAZONE CO., LTD.
- Country
- KOREA, REPUBLIC OF
Authorized representative
- Address
- LUIS MORENO MORA AND FRANCISCO MOSCOSO
- Phone
- 2818889
Product use
ACCESSORY FOR HURO PATH S AND HURO PATH T
About this record
Access comprehensive regulatory information for HURO PATH Filter (FNA) in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID 4776e964dc7de038945b3fe9458643fe and manufactured by CELLTRAZONE CO., LTD.. The device was registered on November 24, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.